For the year ending 2025-12-31, DMAC has $61,371K in assets. $15,647K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 15,647 | |||
| Marketable securities | 44,243 | |||
| Prepaid expenses and other assets | 481 | |||
| Amounts receivable | 258 | |||
| Total current assets | 60,629 | |||
| Deferred offering costs | 400 | |||
| Operating lease right-of-use asset | 197 | |||
| Property, plant and equipment, gross | 295 | |||
| Less accumulated depreciation | 150 | |||
| Property and equipment, net | 145 | |||
| Deposits | 0 | |||
| Total non-current assets | 742 | |||
| Total assets | 61,371 | |||
| Accounts payable | 1,475 | |||
| Accrued liabilities | 3,545 | |||
| Operating lease obligation | 101 | |||
| Finance lease obligation | 11 | |||
| Total current liabilities | 5,132 | |||
| Operating lease obligation, non-current | 124 | |||
| Finance lease obligation, non-current | 4 | |||
| Total non-current liabilities | 128 | |||
| Paid-in capital | 228,829 | |||
| Accumulated other comprehensive income | 50 | |||
| Accumulated deficit | -172,768 | |||
| Total shareholders equity | 56,111 | |||
| Total liabilities and shareholders equity | 61,371 | |||
DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC)